Rilmenidine-d4

Confirm delete?

Rilmenidine-d₄

Zoom

Cat No: 31691

Biochemicals - Isotopically Labeled Standards

Rilmenidine-d4 is intended for use as an internal standard for the quantification of rilmenidine (Item No. 16988) by GC- or LC-MS. Rilmenidine is an antihypertensive agent.{61133} It binds to imidazole receptors in bovine rostral ventrolateral medulla...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

N-(dicyclopropylmethyl)-4,5-dihydro-4,5-d2-2-oxazol-4,5-d2-amine

Correlated keywords:

deuterated deuterium GCMS LCMS hemifumarate hemi fumarate oxaminozoline S 3341 S3341 antihypertensive hypo hyper tension brady cardia

Product Overview:
Rilmenidine-d4 is intended for use as an internal standard for the quantification of rilmenidine (Item No. 16988) by GC- or LC-MS. Rilmenidine is an antihypertensive agent.{61133} It binds to imidazole receptors in bovine rostral ventrolateral medulla homogenates (Ki = 6.1 nM), as well as α2-adrenergic receptors in bovine prefrontal cortex homogenates (Ki = 87 nM). Rilmenidine induces hypotension and bradycardia in anesthetized rats (ED50s = 0.25 and 0.35 mg/kg, respectively). It also reduces mean arterial pressure and renal sympathetic nerve activity in a rabbit model of renal hypertension induced by a renal artery clip when administered at a dose of 2.5 mg/kg.{61134} Rilmenidine (1 µM) increases levels of LC3-II, a marker of autophagy, in PC12 cells.{30143} Formulations containing rilmenidine have been used in the treatment of hypertension.

Size	500 µg
Shipping	dry ice
CAS Number	85047-14-9
Molecular Formula	C₁₀H₁₂D₄N₂O
SMILES	[2H]C(C([2H])([2H])O1)([2H])N=C1NC(C2CC2)C3CC3
Molecular Weight	184,3
Formulation	A solid
Purity	≥99% deuterated forms (d1-d4)
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.